Related Experiment Videos
Management of acute asthma
Pediatrician
|January 1, 1991
Summary
Rapidly reversing airway obstruction in asthma exacerbations is key. Frequent inhaled beta-2 agonists, early systemic corticosteroids, and oxygen for hypoxemia are vital treatments. Monitoring, including peak expiratory flow rate (PEFR) in cooperative patients over 4, ensures effective asthma management.
Area of Science:
- Pulmonology
- Emergency Medicine
- Pharmacology
Background:
- Acute asthma exacerbations present a significant clinical challenge.
- Airway obstruction is the primary pathophysiological feature.
- Prompt and effective treatment is crucial to prevent severe outcomes.
Purpose of the Study:
- To outline the principal goals and methods for treating acute asthma exacerbations.
- To emphasize the importance of rapid reversal of airway obstruction.
- To detail the recommended pharmacological and monitoring strategies.
Main Methods:
- Frequent administration of inhaled beta-2 agonists.
- Early addition of systemic corticosteroids for non-responders.
- Supplemental oxygen for hypoxemia.
- Close monitoring of patient response, including PEFR measurement where appropriate.
Main Results:
- Inhaled beta-2 agonists are the primary treatment for rapid bronchodilation.
- Systemic corticosteroids enhance treatment response in specific patient groups.
- Hypoxemia correction with oxygen is essential.
- PEFR monitoring aids in assessing treatment efficacy in cooperative patients over 4 years old.
Conclusions:
- The cornerstone of acute asthma exacerbation treatment is rapid reversal of airway obstruction.
- A multi-faceted approach involving bronchodilators, corticosteroids, oxygen, and monitoring is recommended.
- Effective management strategies aim to improve patient outcomes and prevent complications.